Compare LUNG & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | HOVR |
|---|---|---|
| Founded | 1995 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.1M | 116.3M |
| IPO Year | 2020 | 2022 |
| Metric | LUNG | HOVR |
|---|---|---|
| Price | $1.96 | $1.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $5.38 | ★ $10.33 |
| AVG Volume (30 Days) | 342.0K | ★ 583.6K |
| Earning Date | 04-29-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,497,000.00 | N/A |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $1.16 |
| 52 Week High | $2.89 | $4.18 |
| Indicator | LUNG | HOVR |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 37.49 |
| Support Level | $1.20 | $1.59 |
| Resistance Level | $2.16 | $2.07 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 12.26 | 19.72 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.